Imaging the myocardium at risk with 99mTc-lactadherin administered after reperfusion in a porcine model
Creators
- 1. Institute for Clinical Medicine, Aarhus University, Aarhus (Denmark)
- 2. Protein Chemistry Laboratory, Department of Molecular Biology and Genetics, Aarhus University, Aarhus (Denmark)
- 3. Department of Cardiology, Aarhus University Hospital, Skejby (Denmark)
- 4. Department of Nuclear Medicine, Aarhus University Hospital, Aarhus (Denmark)
Description
Introduction: Phosphatidylserine is translocated from the inner to the outer leaflet of the plasma membrane in the early stages of apoptosis and necrosis and in reversibly injured cells. In rabbit hearts, ischemia followed by reperfusion results in exposure of phosphatidylserine on myocytes unaffected by apoptosis or necrosis. Lactadherin was recently introduced as a highly sensitive phosphatidylserine ligand. We hypothesized that ischemic myocardial cell damage can be identified by radio-labeled lactadherin and that the ischemic area at risk (AAR) can be visualized retrospectively after reperfusion. Methods: Left anterior descending coronary artery in pigs was occluded for 20 minutes, 45 minutes or 45 minutes preceded by ischemic preconditioning. In all three groups, 99mTc-lactadherin was injected intravenously 30 minutes after reperfusion. The AAR was demarcated by Evans blue and the infarct size by 2,3,5,-triphenyltetrazodium chloride staining. Results: The regional myocardial uptake of 99mTc-lactadherin closely correlated with the AAR (r = .83, P = .001). The area of 99mTc–lactadherin uptake was unaltered by a shorter duration of ischemia and ischemic preconditioning (P = .23) despite significantly different infarct development (P = .001). Conclusion: The results suggest that 99mTc–lactadherin can be used as a sensitive marker for AAR imaging when injected 30 minutes after reperfusion following acute ischemia
Availability note (English)
Available from http://dx.doi.org/10.1016/j.nucmedbio.2013.09.004Additional details
Identifiers
- DOI
- 10.1016/j.nucmedbio.2013.09.004;
- PII
- S0969-8051(13)00203-5;
Publishing Information
- Journal Title
- Nuclear Medicine and Biology
- Journal Volume
- 41
- Journal Issue
- 1
- Journal Page Range
- p. 114-119
- ISSN
- 0969-8051
- CODEN
- NMBIEO
INIS
- Country of Publication
- United Kingdom
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 45088167
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- APOPTOSIS; CHLORIDES; CORONARIES; EVANS BLUE; ISCHEMIA; LIGANDS; MYOCARDIUM; NECROSIS; RABBITS; SWINE; TECHNETIUM 99; UPTAKE
- Descriptors DEC
- ANEMIAS; ANIMALS; ARTERIES; AZO COMPOUNDS; AZO DYES; BETA DECAY RADIOISOTOPES; BETA-MINUS DECAY RADIOISOTOPES; BLOOD VESSELS; BODY; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CHLORINE COMPOUNDS; DISEASES; DOMESTIC ANIMALS; DYES; HALIDES; HALOGEN COMPOUNDS; HEART; HEMIC DISEASES; HOURS LIVING RADIOISOTOPES; INTERMEDIATE MASS NUCLEI; INTERNAL CONVERSION RADIOISOTOPES; ISOMERIC TRANSITION ISOTOPES; ISOTOPES; MAMMALS; MUSCLES; NUCLEI; ODD-EVEN NUCLEI; ORGANIC ACIDS; ORGANIC COMPOUNDS; ORGANIC NITROGEN COMPOUNDS; ORGANIC SULFUR COMPOUNDS; ORGANS; PATHOLOGICAL CHANGES; RADIOISOTOPES; REAGENTS; SULFONIC ACIDS; SYMPTOMS; TECHNETIUM ISOTOPES; VASCULAR DISEASES; VERTEBRATES; YEARS LIVING RADIOISOTOPES
Optional Information
- Copyright
- Copyright (c) 2014 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.